Capital Performance Advisors LLP Exact Sciences Corp Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Exact Sciences Corp stock. As of the latest transaction made, Capital Performance Advisors LLP holds 517 shares of EXAS stock, worth $31,309. This represents 0.01% of its overall portfolio holdings.
Number of Shares
517Holding current value
$31,309% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
674Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.08 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$959 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$868 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$731 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$405 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...